GRISEL DIAZ: Open Payments
NPI 1982928115 · HOMESTEAD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,496 in 49 payments from 19 companies in 2025. Trend: 2023 $1,186 · 2024 $1,447 · 2025 $1,496
Food & beverage: $1,496
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 10 | $230 |
| PharmaEssentia USA Corporation | 4 | $189 |
| GENZYME CORPORATION | 3 | $164 |
| AstraZeneca Pharmaceuticals LP | 5 | $139 |
| Alexion Pharmaceuticals, Inc. | 1 | $118 |
| SOBI, INC | 4 | $98 |
| Merck Sharp & Dohme LLC | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| Pharmacosmos Therapeutics Inc. | 3 | $76 |
| Blueprint Medicines Corporation | 2 | $57 |
Products named: INJECTAFER, BESREMI, ENHERTU, AYVAKIT, Doptelet, Fabhalta, MONOFERRIC, LYNPARZA.
Industry payments across FL — which companies pay providers there.
